Chronic Myeloid Leukemia (CML) Real-Life Database [France]

Study title

CML Observatory

Scientific title

Chronic Myeloid Leukemia (CML) Real-Life Database

Type of study

Observational [Patient Registry]

Phase

Observational [Patient Registry]

Current status

Recruiting

Other trial ID

ClinicalTrials.gov NCT05963061

What is the purpose of the study

This is a study to collect clinical and biological data from patients with CML from diagnosis until after treatment stopped.

Data are collected that are generated in the future (prospective data collection) and that are generated in the past (retrospective data collection).

Key inclusion criteria

This study includes patients of all sexes and ages who:

  • have been diagnosed with Chronic Myeloid Leukemia (CML).

Key exclusion criteria

This study does not include patients who:

  • have received stem cells from someone else (a donor). This is known as an allogeneic transplant or allograft.

Further criteria may apply. Please discuss these with your doctor or study staff.

Estimated primary completion date

April 2034

Where can I find additional information

You can find a study description in the US register ClinicalTrials.gov, This is a database provided by the U. S. National Institutes of Health.

Study sponsor

University Hospital, Clermont-Ferrand

Scientific lead / contact

Study Director: Marc BERGER, MD,
University Hospital, Clermont-Ferrand

Principal investigator

Study centers / principal investigators

France

Annecy Genevois
Centre Hospitalier Annecy Genevois

Caen
University Hospital

Clermont-Ferrand
CHU Clermont-Ferrand

Le Puy-en-Velay
Centre Hospitalier Emile Roux

Limoges
University Hospital

Marseilles
Institut Paoli-Calmettes

Nancy
Central Hospital

Paris
Bicetre Hospital

Paris
Hopital Paul Brousse

Rennes
Rennes University Hospital

Rochefort
Centre Hospitalier de Rochefort

Saint Etienne
Centre Hospitalier Universitaire de Saint Etienne

Toulouse
University Hospital

Versailles
Versailles Hospital